Nevertheless, the data presented herein provide evidence that the modification of membrane stiffness influence TRPC6 signaling and may represent a therapeutic approach for DKD and potentially other glomerular diseases in the future. The gene discussed is TRPC6; the disease is diabetic kidney disease.